Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Maculopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01790802
What this trial is testing

Laser Intervention in Early Age-Related Macular Degeneration Study

Who this might be right for
Age-related Macular Degeneration
Center for Eye Research Australia 292
Large-scale testing (Phase 3)Study completedNCT02462928
What this trial is testing

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 939
Not applicableStudy completedNCT04778436
What this trial is testing

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Who this might be right for
Age Related Macular Degeneration
Laboratoires Thea 10
Not applicableNot Yet RecruitingNCT04875234
What this trial is testing

Vision Improvement for Legally Blind Dry AMD Patients

Who this might be right for
Dry Age-related Macular DegenerationVision Impairment and Blindness
Optimal Acuity Corporation 40
Not applicableStudy completedNCT02174211
What this trial is testing

A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.

Who this might be right for
Age Related Macular Degeneration
King's College Hospital NHS Trust 59
Testing effectiveness (Phase 2)Study completedNCT01344993
What this trial is testing

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration

Who this might be right for
Dry Age Related Macular Degeneration
Astellas Institute for Regenerative Medicine 13
Large-scale testing (Phase 3)Study completedNCT05569148
What this trial is testing

A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Looking for participantsNCT07205887
What this trial is testing

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Who this might be right for
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd. 160
Post-approval studies (Phase 4)Study completedNCT00805649
What this trial is testing

Combined Therapy in Age-Related Macular Degeneration (ARMD)

Who this might be right for
Age-Related Macular Degeneration
Johann Wolfgang Goethe University Hospital 150
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Early research (Phase 1)Study completedNCT03748784
What this trial is testing

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT06635148
What this trial is testing

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyMacular Degeneration
Janssen Research & Development, LLC 274
Not applicableStudy completedNCT02941263
What this trial is testing

Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 20
Not applicableStudy completedNCT02291887
What this trial is testing

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

Who this might be right for
Age-Related Macular Degeneration
Associated Retinal Consultants, Michigan 13
Post-approval studies (Phase 4)Study completedNCT01831947
What this trial is testing

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

Who this might be right for
Macular Degeneration
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Early research (Phase 1)Study completedNCT00473928
What this trial is testing

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Potentia Pharmaceuticals, Inc. 27
Not applicableLooking for participantsNCT07249216
What this trial is testing

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Who this might be right for
Age Related Macular Degeneration
Singapore National Eye Centre 117
Post-approval studies (Phase 4)Study completedNCT00324116
What this trial is testing

Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions

Who this might be right for
Macular Degeneration
Pfizer 81
Large-scale testing (Phase 3)Study completedNCT00826371
What this trial is testing

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
Novartis Pharmaceuticals 114
Not applicableWithdrawnNCT00813514
What this trial is testing

Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?

Who this might be right for
Choroidal NeoVascularizationAge-Related Macular Degeneration
Medical University of Vienna
Next Page